TYNDALL CAPITAL PARTNERS L P sold 0.1% of their position (400.00 shares) of TRAWS PHARMA, INC. on the open market
Open‑market sale worth $1.1K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/11/2019ACC: 0000905718-19-000773
10% Owner
Since Jun 2019
-400.00
Net shares
Net seller
$1.1K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
400.00 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−400.00
Price / share
$2.77
Trade value
$1.11K
% of position
0.1%
9/9/2019
797.09K→796.69K
Total
Net shares
−400.00
Net value
-$1.11K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 9/9/2019 | S · Sale | −400.00 | $2.77 | $1.11K | 0.1% | 797.09K | 796.69K |
| Total | −400.00 | -$1.11K | ||||||
Derivative Transactions0
No derivative transactions reported